---
figid: PMC5962335__fig-4
figlink: /pmc/articles/PMC5962335/figure/f4/
number: F4
caption: 'NAD+biosynthetic pathways in mammals. Four building blocks may be used for
  NAD+synthesis: L-tryptophan, NA, NR, and NAM. The de novo pathway uses L-tryptophan
  to generate, through several intermediate steps, quinolinate. Quinolinate is sequentially
  converted to NAMN, NAAD, and NAD+ by the action of QPRT, NMNATs, and NADS, respectively.
  In the Preiss-Handler pathway, NAPRT converts NA to NAMN, which is then used by
  NMNATs. NR can enter the salvage pathway either by the action of NRK, which generates
  NMN, or by the reaction catalyzed by PNP, which generates NAM. NAM is subsequently
  converted to NMN by NAMPT, the rate-limiting step in the salvage pathway. NRKs can
  also convert NAR to NAMN. All the biosynthetic pathways converge at the level of
  dinucleotide formation catalyzed by the NMNATs. NMNATs use NAMN and NMN with similar
  efficiency. NAD+-consuming reactions catalyzed by PARPs, CD38, and sirtuins release
  NAM that may be use to resynthesize NAD+ in the salvage pathway. NA, nicotinic acid;
  NAD+, nicotinamide adenine dinucleotide; NAAD, nicotinic acid adenine dinucleotide;
  NADS, NAD+ synthetase; NAM, nicotinamide; NAR, nicotinic acid riboside; NR, nicotinamide
  riboside; NRK, NR kinase; NMN, nicotinamide mononucleotide; NAMN, nicotinic acid
  mononucleotide; NAMPT, nicotinamide phosphoribosyltransferase; NAPRT, nicotinic
  acid phosphoribosyltransferase; NMNAT, nicotinamide mononucleotide adenylyl transferase;
  PNP, purine nucleoside phosphorylase; QPRT, quinolinate phosphoribosyltransferase.'
pmcid: PMC5962335
papertitle: Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration.
reftext: Mariana Pehar, et al. Antioxid Redox Signal. 2018 Jun 20;28(18):1652-1668.
pmc_ranked_result_index: '6366'
pathway_score: 0.9646895
filename: fig-4.jpg
figtitle: Nicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5962335__fig-4.html
  '@type': Dataset
  description: 'NAD+biosynthetic pathways in mammals. Four building blocks may be
    used for NAD+synthesis: L-tryptophan, NA, NR, and NAM. The de novo pathway uses
    L-tryptophan to generate, through several intermediate steps, quinolinate. Quinolinate
    is sequentially converted to NAMN, NAAD, and NAD+ by the action of QPRT, NMNATs,
    and NADS, respectively. In the Preiss-Handler pathway, NAPRT converts NA to NAMN,
    which is then used by NMNATs. NR can enter the salvage pathway either by the action
    of NRK, which generates NMN, or by the reaction catalyzed by PNP, which generates
    NAM. NAM is subsequently converted to NMN by NAMPT, the rate-limiting step in
    the salvage pathway. NRKs can also convert NAR to NAMN. All the biosynthetic pathways
    converge at the level of dinucleotide formation catalyzed by the NMNATs. NMNATs
    use NAMN and NMN with similar efficiency. NAD+-consuming reactions catalyzed by
    PARPs, CD38, and sirtuins release NAM that may be use to resynthesize NAD+ in
    the salvage pathway. NA, nicotinic acid; NAD+, nicotinamide adenine dinucleotide;
    NAAD, nicotinic acid adenine dinucleotide; NADS, NAD+ synthetase; NAM, nicotinamide;
    NAR, nicotinic acid riboside; NR, nicotinamide riboside; NRK, NR kinase; NMN,
    nicotinamide mononucleotide; NAMN, nicotinic acid mononucleotide; NAMPT, nicotinamide
    phosphoribosyltransferase; NAPRT, nicotinic acid phosphoribosyltransferase; NMNAT,
    nicotinamide mononucleotide adenylyl transferase; PNP, purine nucleoside phosphorylase;
    QPRT, quinolinate phosphoribosyltransferase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD38
  - NRK
  - NAPRT
  - NAMPT
  - CPSF4
  - PNP
  - NMNAT1
  - L-tryptophan
  - NADS
  - NAD
  - NAAD
  - NAMPT
  - quinolinate
  - NAMN
genes:
- word: CD38
  symbol: CD38
  source: hgnc_symbol
  hgnc_symbol: CD38
  entrez: '952'
- word: NRK
  symbol: NRK
  source: hgnc_symbol
  hgnc_symbol: NRK
  entrez: '203447'
- word: NAPRT
  symbol: NAPRT
  source: hgnc_symbol
  hgnc_symbol: NAPRT
  entrez: '93100'
- word: NAMPT
  symbol: NAMPT
  source: hgnc_symbol
  hgnc_symbol: NAMPT
  entrez: '10135'
- word: NAR
  symbol: NAR
  source: hgnc_alias_symbol
  hgnc_symbol: CPSF4
  entrez: '10898'
- word: PNP,
  symbol: PNP
  source: hgnc_symbol
  hgnc_symbol: PNP
  entrez: '4860'
- word: NMNAT
  symbol: NMNAT
  source: hgnc_alias_symbol
  hgnc_symbol: NMNAT1
  entrez: '64802'
chemicals:
- word: L-tryptophan
  source: ''
  identifier: ''
- word: NADS
  source: MESH
  identifier: C055737
- word: NAD
  source: MESH
  identifier: D009243
- word: NAAD
  source: MESH
  identifier: C053851
- word: NAMPT
  source: MESH
  identifier: C085455
- word: quinolinate
  source: MESH
  identifier: D017378
- word: NAMN
  source: ''
  identifier: ''
diseases: []
figid_alias: PMC5962335__F4
redirect_from: /figures/PMC5962335__F4
figtype: Figure
---
